Synopsis
Synopsis
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
NDC API
0
VMF
0
EDQM
0
USP
0
JP
0
Others
0
FDF Dossiers
0
FDA Orange Book
0
Europe
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
US Patents
0
US Exclusivities
0
Health Canada Patents
US Medicaid
NA
Annual Reports
NA
Regulatory FDF Prices
NA
0
FDF
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
1. 148411-57-8
2. 77224-08-9
3. (2r,3s,4r,5r,6s)-5-amino-6-[(2r,3s,4r,5r,6r)-5-amino-4,6-dihydroxy-2-(hydroxymethyl)oxan-3-yl]oxy-2-(hydroxymethyl)oxane-3,4-diol
4. 2-amino-4-o-(2-amino-2-deoxy-beta-d-glucopyranosyl)-2-deoxy-beta-d-glucopyranose
5. B-d-glucopyranose,2-amino-4-o-(2-amino-2-deoxy-b-d-glucopyranosyl)-2-deoxy-
6. (2r,3r,4r,5s,6r)-3-amino-5-{[(2s,3r,4r,5s,6r)-3-amino-4,5-dihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-6-(hydroxymethyl)oxane-2,4-diol
7. Deacetylated Chitin
8. Poly(d-glucosamine)
9. Schembl186177
10. Chebi:50677
11. Dtxsid80584131
12. Zinc25723126
13. Akos037515792
14. Cs-0239055
15. Chitosan Oligosaccharide Lactate, Average Mn 5,000
16. Q27122179
17. 4-o-(2-amino-2-deoxy-beta-d-glucopyranosyl)-beta-d-glucosamine
18. Wurcs=2.0/1,2,1/[a2122h-1b_1-5_2*n]/1-1/a4-b1
19. 2-amino-4-o-(2-amino-2-deoxy-
20. A-d-glucopyranosyl)-2-deoxy-
21. A-d-glucopyranose
Molecular Weight | 340.33 g/mol |
---|---|
Molecular Formula | C12H24N2O9 |
XLogP3 | -5.2 |
Hydrogen Bond Donor Count | 8 |
Hydrogen Bond Acceptor Count | 11 |
Rotatable Bond Count | 4 |
Exact Mass | 340.14818035 g/mol |
Monoisotopic Mass | 340.14818035 g/mol |
Topological Polar Surface Area | 201 Ų |
Heavy Atom Count | 23 |
Formal Charge | 0 |
Complexity | 390 |
Isotope Atom Count | 0 |
Defined Atom Stereocenter Count | 10 |
Undefined Atom Stereocenter Count | 0 |
Defined Bond Stereocenter Count | 0 |
Undefined Bond Stereocenter Count | 0 |
Covalently Bonded Unit Count | 1 |
Market Place
ABOUT THIS PAGE
71
PharmaCompass offers a list of Chitosan Hydrochloride API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right Chitosan Hydrochloride manufacturer or Chitosan Hydrochloride supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Chitosan Hydrochloride manufacturer or Chitosan Hydrochloride supplier.
PharmaCompass also assists you with knowing the Chitosan Hydrochloride API Price utilized in the formulation of products. Chitosan Hydrochloride API Price is not always fixed or binding as the Chitosan Hydrochloride Price is obtained through a variety of data sources. The Chitosan Hydrochloride Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.
A CHITOSAN manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of CHITOSAN, including repackagers and relabelers. The FDA regulates CHITOSAN manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. CHITOSAN API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of CHITOSAN manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A CHITOSAN supplier is an individual or a company that provides CHITOSAN active pharmaceutical ingredient (API) or CHITOSAN finished formulations upon request. The CHITOSAN suppliers may include CHITOSAN API manufacturers, exporters, distributors and traders.
click here to find a list of CHITOSAN suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
A CHITOSAN DMF (Drug Master File) is a document detailing the whole manufacturing process of CHITOSAN active pharmaceutical ingredient (API) in detail. Different forms of CHITOSAN DMFs exist exist since differing nations have different regulations, such as CHITOSAN USDMF, ASMF (EDMF), JDMF, CDMF, etc.
A CHITOSAN DMF submitted to regulatory agencies in the US is known as a USDMF. CHITOSAN USDMF includes data on CHITOSAN's chemical properties, information on the facilities and procedures used, and details about packaging and storage. The CHITOSAN USDMF is kept confidential to protect the manufacturer’s intellectual property.
click here to find a list of CHITOSAN suppliers with USDMF on PharmaCompass.
CHITOSAN Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of CHITOSAN GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right CHITOSAN GMP manufacturer or CHITOSAN GMP API supplier for your needs.
A CHITOSAN CoA (Certificate of Analysis) is a formal document that attests to CHITOSAN's compliance with CHITOSAN specifications and serves as a tool for batch-level quality control.
CHITOSAN CoA mostly includes findings from lab analyses of a specific batch. For each CHITOSAN CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
CHITOSAN may be tested according to a variety of international standards, such as European Pharmacopoeia (CHITOSAN EP), CHITOSAN JP (Japanese Pharmacopeia) and the US Pharmacopoeia (CHITOSAN USP).